IMZOKITUG
UNII KS4YMP5WRH

Substance Identification & Data

This profile provides standardized clinical and technical data for Imzokitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KS4YMP5WRH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2883771-61-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KS4YMP5WRH

CAS Registry Number

2883771-61-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

IMZOKITUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C179913

National Cancer Institute reference terminology for clinical and research data.

INN ID

13223

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-186

Identifier assigned by the United States Adopted Names Council.

Substance Type

Imzokitug

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Imzokitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Imzokitug

Common Names & Synonyms

BMS 986340 [WHO-DD]

IMZOKITUG [USAN]

Immunoglobulin G1 [de-C-terminal lysine], anti-(human chemokine receptor 8 CCR8) (human monoclonal CCR8.50-g1f γ1-chain), disulfide with human monoclonal CCR8.50-g1f .kappa.-chain, dimer gamma1 heavy chain Homo sapiens (1-445) [VH (Homo sapiens IGHV1-2*06 (85.7%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.9] (26-33.51-58.97-105)) (1-116) -Homo sapiens IGHG1*03, G1m3, nG1m1 CH1 R120, CH3 E12, M14 (CH1 R120 (213) (117-214), hinge 1-15 (215-229), CH2 (230-339), CH3 E12 (355), M14 (357) (340-444), CHS K2>del (445)) (117-445)], (219-219')-disulfide with kappa light chain Homo sapiens (1'-219') [V- KAPPA (Homo sapiens IGKV2D-29*01 (90.0%), CDR-IMGT [11.3.9] (27-37.55-57.94-102)) (1'-116') - Homo sapiens IGKC*01 (100%) Km3 A45.1 (158), V101 (196) (113'-219')]; dimer (225-225'':228-228'')-bisdisulfide, produced in Chinese hamster ovary knockout (CHOK1) cells to lack Glutamine synthetase protein (GS-/-) and Alpha-(1,6)-fucosyltransferase (Fut8-/-), cell line clone 4B10, glycosylated but no fucoyslated glycans (i.e., predominantly G0 and not G0F), glycoform alfa

Immunoglobulin G1 [de-C-terminal-lysine], anti-(human CC chemokine receptor CCR8) (human-Mus musculus monoclonal BMS-986340 γ1-chain), disulfide with human-Mus musculus monoclonal BMS-986340 κ-chain, dimer